期刊文献+

成纤维细胞生长因子23与慢性肾脏病钙磷代谢相关性研究 被引量:3

Correlation of fibroblast growth factor 23 with calcium and phosphorus metabolism in patients with chronic kidney disease
原文传递
导出
摘要 目的研究血清钙(Ca)、磷(P)、甲状旁腺激素(iPTH)、1,25(OH)2D3以及肾功能与成纤维细胞生长因子23(FGF23)的关系。方法将2009年9月至2010年2月中国医科大学附属第一医院住院的慢性肾脏病(CKD)患者58例分为3组,另设对照组20例。采用免疫酶联吸附(ELISA)法测定FGF23及1,25(OH)2D3浓度。全自动生化分析仪测定血清Ca、P、肌酐(Scr)、尿素氮(BUN)浓度,化学免疫发光法测定全段iPTH。结果 FGF23在CKD血清中的质量浓度均高于健康对照组,且随肾小球滤过率(GFR)的降低逐渐升高,在CKD 4,5期FGF23升高明显,与CKD 3期比较差异有统计学意义(P<0.05),1,25(OH)2D3显著下降,与对照组差异有统计学意义(P<0.01)。随着GFR的降低,血清Scr、P、iPTH逐渐升高。Pearson相关分析显示,CKD 3~5期logFGF23与logiPTH、Scr、P呈正相关(r=0.516,P<0.01;r=0.397,P<0.01;r=0.344,P<0.01),与GFR,1,25(OH)2D3呈负相关(r=-0.491,P<0.01;r=-0.413,P<0.01)。结论血清FGF23、iPTH、P随着GFR降低逐渐升高,1,25(OH)2D3逐渐降低,尤以CKD 4~5期明显。当GFR<30时FGF23质量浓度与GFR、血清iPTH、P、1,25(OH)2D3等因素有关。 Objective To evaluate the effects of serum calcium, phosphorus, parathyroid hormone 1,25 (OH) 2 D3 and kidney function on fibroblast growth factor 23 (FGF23). Methods 58 cases with chronic kidney disease (CKD) registered to Division of Nephrology,the First Affiliated Hospital of China Medical University be- tween September 2009 and February 2010 were enrolled and divided into 3 groups according to their glomerular filtration rate. Another 20 healthy subjects were recruited as controls. Serum samples obtained from all subjects were determined for concentrations of FGF23, parathyroid hormone 1,25 (OH)2 D3 by ELISA, for serum levels of calcium (Ca), phosphorus (P), Scr and BUN by automatic biochemistry analyzer, and for intact parathyroid hor- mone (iPTH) by chemiluminescence immunoassay. Results Concentration of serum FGF23 was higher in patients with chronic kidney disease patients than in healthy controls, and was noted to increase along with lower glomerular filtration rate with a significantly higher level in stages 4 and 5 compared with the findings in stage 3 CKD. The level of 1,25(OH)2D3 in CKD patients was significantly lower than that in the controls (P 〈0. 001 ). The serum levels Scr, P and iPTH increased along with lower glomerular filtration rate. Pearson correlation analysis revealed that logFGF23 in stages 3 -5 CKD was positively correlated with logiFFH, Scr and P (r = 0. 516, P 〈0. 01 ;r =0. 379, P 〈0. 01 ; r = 0. 344, P 〈 0.01 ) but negatively correlated with GFR, 1,25 ( OH)2D3 ( r = -0.491,P〈0. 01;r= -0.413,P〈0.01). Conclusion Levels of serum FGF23,iPTH and P increase and 1, 25 (OH)2D3 decreases with the decline of GFR,especially in stages 4 - 5 CKD. Given a GFR below 30 ,the level of FGF23 is correlated with GFR,iPTH,P and [ ,25(OH)2D3.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第11期865-867,共3页 Chinese Journal of Practical Internal Medicine
关键词 成纤维细胞生长因子23 慢性肾脏病 甲状旁腺激素 活性维生素D fibroblast growth factor 23 chronic kidney disease parathyroid hormone 1,25 (OH)2D3
  • 相关文献

参考文献13

  • 1Berndt TJ, Schiavi S, Kumar R. "Phosphatonins" and the regula tion of phosphorus homeostasis [ J ]. Am J Physiol RenalPhysiol, 2005,289 :F1170 - F1182.
  • 2周大燕,黄晶,盛娓娓,刘地川,邓昌明,李文章.成纤维细胞生长因子对大鼠急性心肌梗死后心室重构的影响[J].解放军医学杂志,2009,34(6):691-694. 被引量:9
  • 3Jonsson KB ,Zahradnik R, Larsson T. Fibroblast growth factor23 in oncogenic osteomalacia and X-linked hypophosphatemia [ J ]. N England J Med,2003 ,348 :1656 - 1663.
  • 4田娟,郭敏,王堃.成纤维细胞生长因子受体1和受体2在小鼠肾发育中的表达[J].解放军医学杂志,2010,35(12):1471-1474. 被引量:5
  • 5Gal-Moscovici A, Sprague SM. Role of vitamin D deficiency in chronic kidney disease[ J]. J Bone Miner Res,2007,22(Suppl2) : V91 - V94.
  • 6Torres PU,Friedlander G,MC de Vemejoul,et al. Bone mass does not correlate with the serum fibroblast growth faetor23 in hemodialysis patients [ J ]. Kidney Int,2008,73 : 102 - 107.
  • 7Ferrari SL, Bonjour JP, Rizzol i R. Fibrobl ast growth factor 23 relationship to dietary phosphate and renal phosphate handling in heal thy young men [ J ]. J Clin Endocrinol Metab, 2005,90: 1519 - 1524.
  • 8Ben-Dov IZ, Galitzer H, Lavi-Moshy off, et al. The parathyroid is a target organ for FGF23 in rats [ J ]. J Clin Invest, 2007, 117 : 4003 - 4008.
  • 9Fliser D, Kollerits B, Neyer U, et al. Fibroblast growth factor 23 ( FGF23 ) predicts progression of chronic kidney disease : the Mild to Moderate Kidney Disease (MMKD) Study[ J]. J Am Soc Nephrol,2007,18 (9) :2600 - 2608.
  • 10Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23is a counter regulatory phosphaturic hormone for vitamin d [ J ]. J Am Soc Nephrol,2006 ,17 :1305 - 1315.

二级参考文献23

  • 1Savoye C, Equine O, Tricot O, et al. Left ventricular remodeling after anterior wall acute myocardial infarction in modem clinical practice (from the REmodelage VFntriculaire [ERVE] study group). Am J Cardiol, 2006, 98(9): 1144.
  • 2Yu PJ, Ferrari G, Galloway AC, et al. Basic fibroblast growth factor (FGF-2) : the high molecular weight forms come of age J Cell Bichem,2007, 100(5) : 1100.
  • 3Kardami E, Detillieux K, Ma X, et al. Fibroblast growth factor-2 and c.ardioprotectior. Heart Fail Rev, 2007, 12(3-4): 267.
  • 4Boodhwani M, Voisine P, Ruel M, et al. Comparison of vascular en dothelial growth factor and fibroblast growth factor-2 in a swine mod el of endothelial dysfunction. Eur J Cardiothorae Surg, 2008; 33(4): 645.
  • 5de Souza RR. Aging of myocardial collagen. Biogerontology, 2002, 3 (6) : 325.
  • 6Whittaker P. Unravelling the mysteries of collagen and cicatrix after myocardial infarction. Cardiovasc Res, 1995, 29(6) : 758.
  • 7Detillieux KA, Sheikh F, Kardami E, et al. Biological activities of fibroblast growth factor-2 in the adult myoeardium. Cardiovasc Res, 2003, 57(1), 8.
  • 8Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalrnol, 2005, 40(3): 352.
  • 9Lo J, Hurta R/L Over-expression of K-FGF or bFC-F results in al tered expression of matrix metalloproteinases: Correlations with rns lignant progression and cellular invision. Cell Biol Int, 2002, 26(4): 319.
  • 10Sakakibara Y,-Tambara K, Sakaguchi G, et al. Toward surgical angiogenesis using slove-released basic fibroblast growth factor. Eur J Cardiothorac Surg, 2003, 24(1): 105.

共引文献11

同被引文献14

  • 1Song SH, Kwak IS, Lee DW, et al. The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone [ J ]. Nephrol Dial Transplant, 2009, 24 ( 5 ) : 1534-1538.
  • 2Paoletti E, Bellino D, Cassottana P, et al. Left ventricular hypertrophy in nondiabetic predialysis CKD [ J ]. Am J Kidney Dis ,2005,46 ( 2 ) :320-327.
  • 3Zoccali C, Mallamac F, Tripepi G, et al. Low triiodothyrouine and survival in end-stage renal Diseas [ J ]. Kidney Int, 2006,70(3): 523-528.
  • 4Eckardt KU, Scherhag A, Macdougall IC, et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD [J]. J Am Soc Nephrol, 2009,20 (12) : 2651-2660.
  • 5Monzani F, Di Bello V, Caraccio N. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study [ J ]. J Clin Endocrinol Metab,2001,86 (3) : 1110-1115.
  • 6Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation,2003,107 ( 5 ) : 708-713.
  • 7Zoccali C, Benedetto F, Mallamaci F, et al. Low triiodothyronine and cardiomyopathy in patients with end- stage renal disease [ J ]. J Hypertens, 2006,24 (10) : 2039- 2046.
  • 8Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial [ J ]. JAMA, 2007,298 ( 11 ) : 1291-1299.
  • 9Hsu H J, Wu MS. Fibroblast growth factor 23 : a possible cause of left ventricular hypertrophy in hemodialysis patients[J]. Am J Med Sci,2009,337(2) :116-122.
  • 10李雪锋,李建秋,周薇薇.透析患者血钙血磷代谢紊乱的危险因素分析[J].浙江中医药大学学报,2012,36(2):147-150. 被引量:5

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部